Single or dual antiplatelet therapy after PCI-Reference-Cited by-同舟云学术

Single or dual antiplatelet therapy after PCI

Published:2017-02-09 Issue:5 Volume:14 Page:294-303
ISSN:1759-5002
Container-title:Nature Reviews Cardiology
language:en
Short-container-title:Nat Rev Cardiol

Author:

Miyazaki Yosuke,Suwannasom Pannipa,Sotomi Yohei,Abdelghani Mohammad,Tummala Karthik,Katagiri Yuki,Asano Taku,Tenekecioglu Erhan,Zeng Yaping,Cavalcante Rafael,Collet Carlos,Onuma Yoshinobu,Serruys Patrick W.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://www.nature.com/articles/nrcardio.2017.12.pdf

Reference96 articles.

1. Bertrand, M. E. et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation 98, 1597–1603 (1998).

2. Steinhubl, S. R. et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288, 2411–2420 (2002).

3. Levine, G. N. et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 124, e574–e651 (2011).

4. Task Force Members et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 34, 2949–3003 (2013).

5. Windecker, S. et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35, 2541–2619 (2014).

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial;BMC Medicine;2024-04-23

2. Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials;Cardiovascular Diabetology;2024-04-22

3. Interstitial Fluid Shear Stress Induces the Synthetic Phenotype Switching of VSMCs to Release Pro-calcified Extracellular Vesicles via EGFR-MAPK-KLF5 Pathway;International Journal of Biological Sciences;2024

4. Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial;BMC Cardiovascular Disorders;2023-05-05

5. Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study;AsiaIntervention;2023-03